Ashton Thomas Private Wealth LLC Increases Position in Procter & Gamble Company (The) $PG

Key Points

• Ashton Thomas Private Wealth LLC increased its stake in Procter & Gamble by 6.3% in Q1, now holding 54,334 shares worth approximately $9.26 million.
• CEO Jon R. Moeller and CFO Andre Schulten have recently sold shares, resulting in an 11.16% and 18.11% decrease in their ownership, respectively.
• Procter & Gamble reported a quarterly EPS of $1.48, exceeding analysts' expectations, and has set its FY 2026 guidance between $6.830 and $7.090 EPS.

Ashton Thomas Private Wealth LLC raised its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 6.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 54,334 shares of the company's stock after buying an additional 3,243 shares during the period. Ashton Thomas Private Wealth LLC's holdings in Procter & Gamble were worth $9,260,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also modified their holdings of PG. Nuveen LLC acquired a new position in Procter & Gamble in the 1st quarter valued at about $1,954,941,000. GAMMA Investing LLC boosted its stake in shares of Procter & Gamble by 20,758.5% in the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock valued at $1,355,087,000 after purchasing an additional 7,913,335 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in shares of Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares in the last quarter. Invesco Ltd. increased its stake in Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after buying an additional 2,228,151 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Procter & Gamble by 15.8% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock worth $2,728,430,000 after buying an additional 2,224,912 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CEO Jon R. Moeller sold 40,119 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $6,309,515.13. Following the completion of the sale, the chief executive officer directly owned 319,375 shares of the company's stock, valued at approximately $50,228,106.25. This represents a 11.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Andre Schulten sold 11,638 shares of Procter & Gamble stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the transaction, the chief financial officer directly owned 52,642 shares in the company, valued at $8,279,007.34. The trade was a 18.11% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 120,181 shares of company stock worth $18,918,012. 0.20% of the stock is currently owned by company insiders.

Procter & Gamble Stock Up 0.6%

Procter & Gamble stock opened at $160.08 on Monday. The stock has a market cap of $374.65 billion, a PE ratio of 24.59, a P/E/G ratio of 4.22 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The stock's fifty day moving average is $156.41 and its two-hundred day moving average is $162.21. Procter & Gamble Company has a 1-year low of $149.91 and a 1-year high of $180.43.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. The business had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business's revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were given a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.6%. The ex-dividend date was Friday, July 18th. Procter & Gamble's payout ratio is currently 64.98%.

Analyst Ratings Changes

Several equities analysts have commented on PG shares. BNP Paribas reissued an "outperform" rating and issued a $177.00 price target on shares of Procter & Gamble in a research report on Friday, August 15th. Barclays set a $164.00 target price on Procter & Gamble and gave the company an "equal weight" rating in a report on Thursday, July 31st. Evercore ISI restated an "in-line" rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Finally, Wells Fargo & Company decreased their price objective on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $175.12.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.